{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "SAR-CoV-2 Mpro",
      "herbal compounds",
      "potential candidates",
      "theoretical methods"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "36719113",
  "DateCompleted": {
    "Year": "2023",
    "Month": "02",
    "Day": "03"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "03",
    "Day": "29"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "01",
        "Day": "04"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1080/07391102.2021.2023646"
    ],
    "Journal": {
      "ISSN": "1538-0254",
      "JournalIssue": {
        "Volume": "41",
        "Issue": "5",
        "PubDate": {
          "Year": "2023",
          "Month": "Mar"
        }
      },
      "Title": "Journal of biomolecular structure & dynamics",
      "ISOAbbreviation": "J Biomol Struct Dyn"
    },
    "ArticleTitle": "Traditional herbal compounds as candidates to inhibit the SARS-CoV-2 main protease: an <i>in silico</i> study.",
    "Pagination": {
      "StartPage": "1603",
      "EndPage": "1616",
      "MedlinePgn": "1603-1616"
    },
    "Abstract": {
      "AbstractText": [
        "COVID-19, a disease caused by the SARS-CoV-2 virus, is responsible for a pandemic since March 2020 and it has no cure. Therefore, herein, different theoretical methods were used to obtain potential candidates from herbal compounds to inhibit the SARS-CoV-2 main protease (M<sup>pro</sup>). Initially, the 16 best-scored compounds were selected from a library containing 4066 ligands using virtual screening by molecular docking. Among them, six molecules (physalin B 5,6-epoxide (PHY), methyl amentoflavone (MAM), withaphysalin C (WPC), daphnoline or trilobamine (TRI), cepharanoline (CEP) and tetrandrine (TET)) were selected based on Lipinski's rule and ADMET analysis as criteria. These compounds complexed with the M<sup>pro</sup> were submitted to triplicate 100<b>\u2009</b>ns molecular dynamics simulations. RMSD, RMSF, and radius of gyration results show that the overall protein structure is preserved along the simulation time. The average \u0394G<sub>binding</sub> values, calculated by the MM/PBSA method, were -41.7, -55.8, -45.2, -38.7, -49.3, and -57.9<b>\u2009</b>kcal/mol for the PHY-M<sup>pro</sup>, MAM-M<sup>pro</sup>, WPC-M<sup>pro</sup>, CEP-M<sup>pro</sup>, TRI-M<sup>pro</sup>, and TET-M<sup>pro</sup> complexes, respectively. Pairwise decomposition analyses revealed that the binding pocket is formed by His41-Val42, Met165-Glu166-Leu167, Asp187, and Gln189. The PLS regression model generated by QSPR analysis indicated that non-polar and polar groups with the presence of hydrogen bond acceptors play an important role in the herbal compounds-M<sup>pro</sup> interactions. Overall, we found six potential candidates to inhibit the SARS-CoV-2 M<sup>pro</sup> and highlighted key residues from the binding pocket that can be used for future drug design. Communicated by Ramaswamy H. Sarma."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Instituto Federal de Educa\u00e7\u00e3o, Ci\u00eancia e Tecnologia de S\u00e3o Paulo, Catanduva, Brazil."
          }
        ],
        "LastName": "de Oliveira",
        "ForeName": "Osmair Vital",
        "Initials": "OV"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Instituto de Qu\u00edmica, Universidade Estadual de Campinas, Campinas, Brazil."
          }
        ],
        "LastName": "Cristina Andreazza Costa",
        "ForeName": "Maria",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Instituto Federal de Educa\u00e7\u00e3o, Ci\u00eancia e Tecnologia do Sul de Minas, Muzambinho, Brazil."
          }
        ],
        "LastName": "Marques da Costa",
        "ForeName": "Ricardo",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Instituto Federal de Educa\u00e7\u00e3o, Ci\u00eancia e Tecnologia de S\u00e3o Paulo, Catanduva, Brazil."
          }
        ],
        "LastName": "Giordano Viegas",
        "ForeName": "Rafael",
        "Initials": "R"
      },
      {
        "Identifier": [
          "0000-0002-2748-0783"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Chemical, Paper, and Biomedical Engineering, Miami University, Oxford, OH, USA."
          }
        ],
        "LastName": "Paluch",
        "ForeName": "Andrew S",
        "Initials": "AS"
      },
      {
        "Identifier": [
          "0000-0001-5677-0299"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Instituto de Qu\u00edmica, Universidade Estadual de Campinas, Campinas, Brazil."
          }
        ],
        "LastName": "Miguel Castro Ferreira",
        "ForeName": "M\u00e1rcia",
        "Initials": "M"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Biomol Struct Dyn",
    "NlmUniqueID": "8404176",
    "ISSNLinking": "0739-1102"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "EC 3.4.22.-",
      "NameOfSubstance": "3C-like proteinase, SARS-CoV-2"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Protease Inhibitors"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapy"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Docking Simulation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Dynamics Simulation"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Protease Inhibitors"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "COVID-19 Drug Treatment"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Phytotherapy"
    }
  ]
}